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The gene ptsp, which specifies HPr on the E. coli genome, was cloned on the plasmid pBR322 and was 
expressed in recA cells. HPr was produced in large amounts and was characterized by several criteria. 
Plasmid HPr E. coli Phosphoenolpyruvate-dependent phosphotransferase system 
1. INTRODUCTION 
The histidine-containing protein HPr plays an 
essential role in the uptake of many carbohydrates 
by facultative and obligate anaerobic bacteria [ 11. 
It mediates the transfer of the phosphate group of 
phosphoenofpyruvate o the C-l or C-6 position of 
the sugars which have been taken up into the cells 
via proteins in the plasma membrane; the sugar- 
phosphates thus formed can directly enter 
metabolic pathways. HPr, of it4, approx. 7700, has 
been purified from Staphylococcus aureus [2] and 
from Bacillus subtilis [3]; a somewhat larger HPr 
(MI approx. 9000) has been purified from 
Salmonella [4] and Escherichia coli [5]. There are 
only small amounts of HPr present in wild-type 
bacteria; in order to obtain yields of HPr adequate 
for study relatively large masses of organisms 
(lOOg-2 kg) and, therefore, large volumes of 
bacterial cultures, have to be used [5-71. 
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Moreover, and for the same reason, the postulated 
phosphorylation and dephosphorylation of HPr 
could be seen only with the purified protein and 
could not be demonstrated in intact or broken 
cells. 
Here, we report the cloning, on the plasmid 
pBR322, of ptsti (the gene that specifies HPr on 
the E. coli genome) and its expression; we show 
that the material thus made is indeed HPr and that 
it can be phosphorylated by phosphoenolpyruvate. 
Growth of cells bearing many copies of this 
plasmid enables over 100mg of highly purified 
HPr to be obtained from only 5 litres of bacterial 
culture. 
2. MATERIALS AND METHODS 
2.1. Sub-cloning of DNA from phase hJM29 into 
plasmid pBR322 
We have described the isolation of a specialized 
transducing phage hJM29 that can complement 
ptsH mutants of E. coli [8] and from which a 
polypeptide of M, 9000 can be expressed in UV- 
irradiated cells; we therefore concluded that 
X JM29 carries the ptsH+ gene [9]. To sub-clone the 
appropriate region of DNA that carries this func- 
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Fig. 1. Construction of plasmids pABl5 and pAB65 from the specialized transducing phage XJM29. The plasmid maps 
are shown with their ends at the AvaI restriction site in plasmid pBR322 DNA. The Kl-K2 fragment of plasmids pAB15 
and pAB65 is 0.8 kb long; XJM29 is drawn to half this scale; (m) hDNA; (m) pBR322 DNA; ( -) cloned E. coli 
DNA. ApR denotes the ampicillin resistance gene of pBR322; the sites at which restriction enzymes act are given as: 
E, EcoRI; B, BarnHI; H, Z-ZindIII; K, KpnI. 
tion into plasmid pBR322, the following procedure 
was adopted: 
(i) DNA isolated from hJM29 was digested with 
the restriction endonuclease BarnHI, and the 
B11.3-Bl fragment (21.1 kilobases (kb) in 
length; fig. 1) was ligated into the BarnHI site 
of plasmid pBR322. The resultant plasmid, 
pABl5, was 25.5 kb long; it could complement 
p&H mutants (i.e., it enabled such mutants 
now to grow upon sorbitol [8]) and thus carried 
p&H+. 
(ii) In order to remove much of the 17 kb of ADNA 
carried on pAB15, this plasmid was digested 
with both EcoRI and BamHI. This resulted in 
the release of the 5.34 kb fragment E54.3-Bl 
(fig. 1) and of a 3.98 kb fragment from the 
DNA originally in pBR322. Ligation of these 
two fragments gave rise to the 9.32 kb plasmid 
pAB65, which still carried the ampicillin 
resistance marker. Since it complemented ptsH 
recA mutants of E. coli and expressed a 
polypeptide of M, 9000 in mini-cells, it also car- 
ried ptsW. 
2.2. Other methods 
The methods used for isolation of DNA, treat- 
ment with restriction endonucleases and ligases 
and transformation of competent E. coli strains 
have been described [8,10]. The presence of func- 
tional HPr in whole cells was assumed from the 
ability of such cells to grow upon sorbitol as sole 
carbon source [8]; it was confirmed by establishing 
that sonic extracts of such cells restored the ability 
of similar extracts of a ptsN-strain of E. co/i to 
catalyse the phosphoenolpyruvate-dependent 
phosphorylation of methyl a-glucoside. For this, 
the procedure used was essentially that in [I I]; full 
details are given in the legend of table 2. 
3. RESULTS AND DISCUSSION 
3.1. Purification of HPr from cells carrying the 
multicopy plasmid pAB65 
The recA E. coli strain PB13 transformed with 
the plasmid pAB65 was used as a source of HPr. 
A 5 1 culture of the organism grown in Luria Broth, 
supplemented with ampicillin (1OOpg. ml-‘) to 
stabilize the plasmid, was grown at 37’C; the cells 
(10.6g wet wt) were harvested by centrifugation 
for 10min in a Sorvall RCSB centrifuge, GSA 
rotor, at 10000 x g. They were suspended in 70ml 
1OmM Tris-HCI (pH7.6) and were disrupted by 
sonic oscillation for 8 x 15 s (6pm peak-to-peak) at 
4°C with an MSE 8-75 MK2 sonicator. The DNA 
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and RNA were digested by adding 0.5 mg RNase 
and 0.5 mg DNase and incubating for 30min. Cell 
debris was removed by centrifugation in a Sorvall 
RCSB centrifuge, SS-34 rotor, at 48000 x g for 
2 h; the supernatant solution from this procedure 
was dialysed against 1OmM Tris-HCl (pH7.6) at 
4°C. The resultant material was chromatographed 
on a Whatman DE-52 DEAE column (2.5 x 7 cm) 
which had been pre-equilibrated with 1OmM 
Tris-HCl (pH 7.6); a linear concentration gradient 
(500ml) of O-1OOmM NaCl in the Tris-HCl buf- 
fer was used and 5 ml fractions were collected. 
Those fractions that contained HPr were pooled 
and dialysed against 50mM ammonium bicar- 
bonate (pH8.0); they were freeze-dried. The 
material thus obtained was redissolved in 2ml 
10 mM Tris-HCl (pH 7.6) and was further purified 
by gel permeation chromatography on a Sephadex 
G-50 column (2 x 57 cm) in 1OmM Tris-HCl 
(pH 7.6). 
HPr was eluted from the DEAE column between 
30 and 40mM NaCl (fig. 2a). Analysis by 
SDS-PAGE, using 18% gels [9] showed the major 
polypeptide present to have an M, of 9000 although 
some other peptides of higher A4r, were also present. 
However, further purification on Sephadex G-50 
(fig. 2b) removed those contaminating peptides. 
After two-dimensional electrophoresis of the 
resulting material (ampholines LKB, pH 3.5-lo), 
only one spot was revealed by either silver or 
Table 1 
Amino acid composition of HPr 
ELUTION VOLUME (ml) 
I I 
ELUTION VOLUME (ml1 
Fig. 2. Purification of HPr. HPr was initially purified by 
DEAE ion-exchange chromatography (a). The fractions 
that contained HPr are shown by a bar. After concen- 
trating, by freeze drying, HPr was further purified by gel 
permeation chromatography on Sephadex GSO (b). The 
HPr was identified by the characteristic absorbance of 
phenylalanine at 258 nm. 
Amino 
acid 
(mol. residue.mol-‘) No. of resi- 
Composition according to: dues in se- 
This PI WI 
quence [4] 
papera (24 h hydrolyses) 
ASP 
Thr 
Ser 
GlU 
Pro 
GIY 
Ala 
CYS 
Val 
Met 
Ile 
Leu 
Tyr 
Phe 
His 
LYS 
Aw 
Trp 
3.2 3.6 5.2 3.0’ 
9.8b 10.0 8.9 9.0 
6.Sb 6.9 6.1 6.0 
14.5 13.5 14.8 14.0d 
2.6 2.2 2.6 2.0 
6.3 6.7 7.2 6.0 
9.8 9.4 8.7 9.0 
n.d. <0.05 < 0.05 none 
7.5 7.1 6.4 7.0 
1.9 2.1 1.6 2.0 
3.1 3.4 3.5 3.0 
7.8 8.5 8.0 8.0 
none <0.05 0.50 none 
4.0 4.0 4.3 4.0 
2.3 2.0 2.0 2.0 
7.5 8.1 7.1 8.0 
1.0 0.96 1.6 1.0 
n.d. <O.l n.d. none 
a Samples (10nmol) of salt-free HPr, dissolved in 6M 
HCl containing 2-mercaptoethanol (O.OScr/o) and 
phenol (O.OS~o), were hydrolysed at 105°C for 24, 48 
and 72 h [17]. No differences were observed between 
these times of hydrolysis except for Thr and Ser; only 
the data for 72 h are shown 
b Determined after extrapolation to zero time 
’ Consists of 2Asn and 1 Asp from sequence data 
d Consists of 7Gln and 7Glu from sequence data 
n.d. Not done as sequence reported none 
290 
Volume 149, number 2 FEBS LETTERS November 1982 
Coomassie blue staining, which indicated that the 
HPr thus prepared was essentially pure. The total 
yield obtained was 98 rt 3 mg. According to the 
amino acid analysis of the protein (table l), the 
material was devoid of tyrosine; this accorded well 
with the distribution of amino acids reported [4] 
for the Salmonella HPr sequence. In further agree- 
ment with [4] but in contrast with [5,12], spectral 
analysis revealed no shoulder at 280nm, which in- 
dicated the absence of tyrosine and tryptophan. 
That the purified protein was indeed functional 
HPr was shown in two main ways: 
(i) It restored the activity of an extract of the 
p&H-strain JM1681 of E. coli to effect the 
overall phosphorylation of methyl [14C]gluco- 
side when incubated with it and with phospho- 
enolpyruvate (table 2). 
chewan, Saskatoon); antibodies raised against 
Dr Waygood’s purified HPr reacted with the 
material purified from PBl3(pAB65). In agree- 
ment with [13] our HPr-antibodies did not 
(ii) Antibodies raised against it, which did not 
react with extracts of ptsH mutants, were 
shown to react both with extracts ofptsH+ cells 
and with a sample of HPr purified from a dif- 
ferent strain of E. coli and kindly given to us 
by Dr E.B. Waygood (University of Saskat- 
Table 2 
Production of methyl cu-glucoside &phosphate using in- 
creasing amounts of purified HPr 
nmol HPr added nmol methyl a-glucoside 
phosphate produced 
0 0 
0.018 44.8 
0.035 39.8 
0.070 58.7 
0.350 60.5 
0.700 69.6 
The incubation mixtures contained in lOOa final vol. 
lOmM KF, 5mM MgCl2, 5mM phosphoenofpyruvate, 
1 mM methyl cu-[U-14C]glucoside (0.25&i: Amersham 
International plc), 50 mM potassium phosphate (pH 7.2) 
and a sonic extract of a ptsH strain of E. coli (1 mg dry 
mass total). Various amounts of HPr were added as 
shown. After 30min at 37”C, the reaction was stopped 
by adding 900~1 ice-cold water; samples (50~1) were ad- 
sorbed onto Whatman DE81 paper discs (2.3cm) and 
unphosphorylated material was washed off with lOOm1 
water. The radioactivity of the dried discs, suspended in 
IO ml of scintillation fluid (0.4% 2,5-diphenylox~ole in 
80% (v/v) toluene and 20% (v/v) methoxyethanol), was 
Fig. 3. In vitro phosphorylation of HPr by [32P]phos- 
phoenolpyruvate. An E. coli strain lacking plasmid 
pAB65 did not produce a detectable phosphorylated 
HPr (track 1) whereas a strain containing plasmid 
pAB65 did (track 2). This phosphorylated protein had a 
M, of 9000 and electrophoresed with HPr stained by 
Coomassie blue. The two other phospho~lated proteins 
observed are of higher M, and are formed independently 
assayed in a Tri-carb scintillation spectrometer of the presence of the plasmid pAB65. 
291 
Volume 149, number 2 FEBS LETTERS November 1982 
react against the fructose-specific carrier pro- 
tein FPr [14]. 
The HPr expressed by the plasmid pAB65 could 
PI 
be phosphorylated by [32P]phosphoenolpyruvate 
[15] even in crude extracts of the cells, though no 
phosphorylated HPr was detected in extracts of 
cells lacking the plasmid (fig. 3). This may be be- 
cause the normal levels of HPr are very low, 
and/or because the phosphorylated form of HPr is 
very unstable at pH7.2 [16]; it would be expected 
that the balance between phosphorylation and de- 
phosphorylation would be tilted towards the ac- 
cumulation of phospho-HPr only if the concentra- 
tions of HPr were raised considerably, as happens 
in organisms that carry the multicopy plasmid 
pAB65. 
131 
141 
[51 
161 
[71 
WI 
191 
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